CompanyHealthcare Drug Discovery and Delivery
Arpeggio Bio
Arpeggio Bio leverages AI and RNA-sequencing to develop drugs targeting hard-to-drug transcription factors, focusing on innovative therapies for diseases like melanoma.
BiotechGenomicsDrug discovery